Roberto Scandurra

Prof. Roberto Scandurra


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
FVFrancesca Veronesi
Francesca Veronesi
Gianluca GiavaresiGianluca Giavaresi
Gianluca Giavaresi
MFMilena Fini
Milena Fini
GLGiovanni Longo
Giovanni Longo
CICaterina Alexandra Ioannidu
Caterina Alexandra Ioannidu
RSRoberto Scandurra
Roberto Scandurra

9 October 2007 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ADAnna Scotto d'Abusco
Anna Scotto d'Abusco
VCValentina Calamia
Valentina Calamia
CCClaudia Cicione
Claudia Cicione
Brunella GrigoloBrunella Grigolo
Brunella Grigolo
LPLaura Politi
Laura Politi
RSRoberto Scandurra
Roberto Scandurra
The aim of this study was to determine the effects of glucosamine on matrix metalloprotease (MMP) production, on mitogen-activated protein kinase (MAPK) phosphorylation, and on activator protein (AP)-1 transcription factor activation in human chondrocytes. The human immortalized cell line lbpva55 and healthy human chondrocytes (obtained from healthy donors) were subjected to challenge with 10 ng/ml IL-1β after pretreatment with 2.5 or 10 mmol/l glucosamine. MMP mRNA expression levels were evaluated using quantitative real-time PCR, and MMP protein production levels were evaluated in the culture supernatant using ELISA. MAPK phosphorylation was evaluated using Western blotting. AP-1 transcription factor activation was evaluated by measuring AP-1 DNA-binding activity. After IL-1β stimulation, levels of MMP-1, MMP-3 and MMP-13 production were markedly increased. Treatment with 2.5 and 10 mmol/l glucosamine reduced expression of these metalloproteases. MMP expression is regulated by transcription factors such as the AP-1 complex, which is activated by phosphorylated MAPKs. IL-1β stimulated phosphorylation of c-jun amino-terminal kinase, p38 MAPK and extracellular signal-regulated kinase-1/2. Glucosamine inhibited c-jun amino-terminal kinase and p38 phosphorylation, and consequently c-jun binding activity. These findings demonstrate, for the first time, that glucosamine inhibits IL-1β-stimulated MMP production in human chondrocytes by affecting MAPK phosphorylation.

1 January 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
DSD. Stoppoloni
D. Stoppoloni
LPL. Politi
L. Politi
MLMartina Leopizzi
Martina Leopizzi
Silvana GaetaniSilvana Gaetani
Silvana Gaetani
RGR. Guazzo
R. Guazzo
ADAnna Scotto d'Abusco
Anna Scotto d'Abusco


29 January 2010 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ADAnna Scotto d'Abusco
Anna Scotto d'Abusco
LPLaura Politi
Laura Politi
CGCesare Giordano
Cesare Giordano
RSRoberto Scandurra
Roberto Scandurra
Introduction: Nuclear factor-κB (NF-κB) transcription factor regulates several cell signaling pathways, such as differentiation and inflammation, which are both altered in osteoarthritis. Inhibitor κB kinase (IKK)α and IKKβ are kinases involved in the activation of the NF-κB transcription factor. The aim of the present study was to determine the effects of glucosamine (GlcN), which is administered in the treatment of osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-deoxy-β-D-glucose (NAPA) derivative on IKK kinases and, consequently, on NF-κB activation in human chondrocytes. Methods: The human chondrosarcoma cell line HTB-94 and human primary chondrocytes were stimulated with tumor necrosis factor (TNF)α after pre-treatment with GlcN or NAPA. Gene mRNA expression level was evaluated by real-time PCR. Inhibitor κB protein (IκB)α phosphorylation and p65 nuclear re-localization were analyzed by Western blotting; IKKα nuclear re-localization was also investigated by immunocytochemistry and Western blotting. IKK kinase activity was studied by in vitro kinase assay. Results: After TNFα stimulation, the mRNA expression level of some of the genes under NF-κB control, such as interleukin (IL)-6 and IL-8, increased, while treatment with GlcN and NAPA reverted the effect. We investigated the possibility that GlcN and NAPA inhibit IKK kinase activity and found that NAPA inhibits the IKKα kinase activity, whereas GlcN does not. Interestingly, both GlcN and NAPA inhibit IKKα nuclear re-localization. Conclusions: Our results demonstrate that glucosamine and its peptidyl derivative can interfere with NF-κB signaling pathway by inhibiting IKKα activity in human chondrocytes. However, the mechanism of action of the two molecules is not completely overlapping. While NAPA can both specifically inhibit the IKKα kinase activity and IKKα nuclear re-localization, GlcN only acts on IKKα nuclear re-localization.

24 June 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
RSRoberto Scandurra
Roberto Scandurra
ADAnna Scotto d'Abusco
Anna Scotto d'Abusco
GLGiovanni Longo
Giovanni Longo
Improving the biocompatibility of implants is an extremely important step towards improving their quality. In this review, we recount the technological and biological process for coating implants with thin films enriched in titanium carbide (TiC), which provide improved cell growth and osseointegration. At first, we discuss the use of a Pulsed Laser Ablation Deposition, which produced films with a good biocompatibility, cellular stimulation and osseointegration. We then describe how Ion Plating Plasma Assisted technology could be used to produce a nanostructured layer composed by graphitic carbon, whose biocompatibility is enhanced by titanium oxides and titanium carbide. In both cases, the nanostructured coating was compact and strongly bound to the bulk titanium, thus particularly useful to protect implants from the harsh oxidizing environment of biological tissues. The morphology and chemistry of the nanostructured coating were particularly desirable for osteoblasts, resulting in improved proliferation and differentiation. The cellular adhesion to the TiC-coated substrates was much stronger than to uncoated surfaces, and the number of philopodia and lamellipodia developed by the cells grown on the TiC-coated samples was higher. Finally, tests performed on rabbits confirmed in vivo that the osseointegration process of the TiC-coated implants is more efficient than that of uncoated titanium implants.